RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
4 recruiting psoriasis studies with a site in Webster, TX.
Sponsor: Bristol-Myers Squibb
Arlington, TX · Cypress, TX · Dallas, TX · +119 more sites
Sponsor: Oruka Therapeutics, Inc.
Frisco, TX · Houston, TX · Webster, TX · +19 more sites
Sponsor: Vanda Pharmaceuticals
San Antonio, TX · Webster, TX · +8 more sites
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.